₹851.15
▲ +4.23 +0.50%
29 Jul 2026
NSE Listed · Pharmaceuticals
Sakar Healthcare Limited (SAKAR)
Volume: 28,242Avg Vol 1W: 1,88,160Avg Vol 1M: 1,79,15552W Range:₹311₹960
Key Ratios
Checked just nowMarket Cap₹1,894 Cr
Current Price₹851.15
Previous Close₹846.92
High / Low (52w)₹960 / ₹311
Volume28,242
Avg Vol (1W)1,88,160
Avg Vol (1M)1,79,155
Stock P/E171.6
Book Value₹145.82
Dividend Yield0%
ROE9.4%
ROA6.34%
Revenue (TTM)—
Revenue Growth15.8%
Profit Margin12.11%
Total Debt₹54 Cr
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹4.96
P/B5.84
Debt / Equity0.17
50 DMA₹824.62
200 DMA₹551.11
Day change+0.50%
Price Chart
₹851.15▲ 143.22% · 1Y
2025-07-292026-07-29
20-day avg volume: 1.9L shares
Pros
- Company is almost debt-free.
Cons
- Stock trades at a high P/E of 172.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹43 Cr | ₹43 Cr | ₹50 Cr | ₹53 Cr | ₹58 Cr | ₹70 Cr | ₹71 Cr | ₹73 Cr |
| EBITDA | ₹7 Cr | ₹7 Cr | ₹10 Cr | ₹8 Cr | ₹7 Cr | ₹13 Cr | ₹20 Cr | ₹16 Cr |
| Net Profit | ₹5 Cr | ₹5 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹10 Cr | ₹11 Cr | ₹10 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹43 Cr | ₹179 Cr | ₹50 Cr | ₹53 Cr | ₹58 Cr | ₹70 Cr | ₹71 Cr | ₹73 Cr |
| EBITDA | ₹7 Cr | ₹30 Cr | ₹10 Cr | ₹8 Cr | ₹7 Cr | ₹13 Cr | ₹20 Cr | ₹16 Cr |
| Net Profit | ₹5 Cr | ₹18 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹10 Cr | ₹11 Cr | ₹10 Cr |
| EPS | — | 7.95 | — | — | — | — | — | — |
Balance Sheet
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Total Assets | ₹115 Cr | ₹178 Cr | ₹268 Cr | ₹336 Cr | ₹389 Cr | ₹415 Cr |
| Total Liabilities | ₹34 Cr | ₹79 Cr | ₹140 Cr | ₹163 Cr | ₹126 Cr | ₹130 Cr |
| Equity | ₹81 Cr | ₹98 Cr | ₹127 Cr | ₹173 Cr | ₹262 Cr | ₹285 Cr |
| Total Debt | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Operating | ₹22 Cr | ₹15 Cr | ₹36 Cr | ₹38 Cr | ₹142 Cr | ₹36 Cr |
| Investing | ₹-22 Cr | ₹-47 Cr | ₹-90 Cr | ₹-74 Cr | ₹-52 Cr | ₹-31 Cr |
| Financing | ₹3 Cr | ₹32 Cr | ₹55 Cr | ₹41 Cr | ₹27 Cr | ₹-3 Cr |
| Free Cash Flow | ₹13 Cr | ₹4 Cr | ₹36 Cr | ₹38 Cr | ₹142 Cr | ₹36 Cr |
Shareholding
Promoter 52.52% Institutions 23.51% Public 23.98%
Efficiency & Working Capital
ROCE8.4%
Interest Coverage3.5
Dividend Payout—
Debtor Days63 d
Inventory Days90 d
Payable Days43 d
Cash Conversion Cycle109 d
Working Capital Days153 d
Shareholding Details
As of 2026-06-30
Promoter52.5%
FII12.1%
DII11.4%
Institutions23.5%
Public24%
Promoter Pledge0%
No. of Shareholders14,734
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 54.2% | 53.2% | 53.2% | 53.2% | 53.2% | 53.6% | 53.6% | 52.9% | 52.9% | 52.9% | 52.9% | 52.5% |
| FIIs | 14% | 13.8% | 13.5% | 13.5% | 13.4% | 13.6% | 13.6% | 13.4% | 13.3% | 13% | 12.9% | 12.1% |
| DIIs | 0% | 10.6% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 11.4% | 11.3% | 11.4% |
| Public | 31.8% | 22.5% | 33.3% | 33.3% | 33.4% | 32.8% | 32.8% | 33.7% | 33.8% | 22.7% | 22.9% | 24% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 7,299 | 7,001 | 7,386 | 7,313 | 7,867 | 8,598 | 8,608 | 8,115 | 7,565 | 7,069 | 9,580 | 14,734 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Sanjay S Shah | Shareholding of Promoter and Promoter Group | 45% | 1.00 Cr |
| Tata Capital Healthcare Fund Ii | Public Shareholding | 10.4% | 23,09,910 |
| Hbm Healthcare Investments (cayman) Ltd | Public Shareholding | 6.7% | 15,00,000 |
| Shah Aarsh | Shareholding of Promoter and Promoter Group | 6.3% | 14,07,500 |
| Cobra India (mauritius) Limited | Public Shareholding | 3.9% | 8,75,780 |
| Ritaben Shah | Shareholding of Promoter and Promoter Group | 1.1% | 2,45,000 |
| Shah Ayushi | Shareholding of Promoter and Promoter Group | 0.1% | 24,000 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Sanjay S Shah. | Chairman & Managing Director | 2025 |
| Aarsh S Shah | Joint Managing Director | 2025 |
| Visalakshi Chandramouli | Non-Exec & Non-Independent Dir | 2025 |
| JIGNESH MUKUNDBHAI PARIKH | Independent Non Exe. Director | 2025 |
| Khyati B. Shah | Independent Non Exe. Director | 2025 |
| Sunil Marathe | Whole Time Director- Technical | 2025 |
| Megha Kamal Samdani | Independent Non Exe. Director | 2025 |
| Reeya Kothari | Independent Non Exe. Director | 2025 |
| Hiral Vinodbhai Patel | Independent Non Exe. Director | 2025 |
| Bharat Soni | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Manufacturing of Pharmaceutical pro | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 25 | 22 | 22 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-24 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 4 | 0 | 4 |
| 2025 | 0 | 0 | 0 | 3 | 0 | 3 |
| 2025 | 0 | 0 | 0 | 2 | 0 | 2 |
Company Information
🌐 www.sakarhealthcare.com ↗
📍 10/13 Nr MN Desai Petrol Pump, Sarkhej Bavla Highway, Changodar, Gujarat, 382213
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search